Identifying Hypercortisolism in Patients with Resistant Diabetes - Episode 10

Approaching Treatment in Hypercortisolism

Published on: May 20, 2024

Hanford Yau, MD , Ralph DeFronzo, MD , Pam Kushner, MD , Honey East, MD, Christopher Lucci, MD

Panelists review current guidelines for treating hypercortisolism, noting the need for guidelines to align with recent advancements, and share their own clinical practice approaches.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Defining Resistant Diabetes

EP. 2: Differentiating Medication Non-Adherence From Underlying Comorbidities

EP. 3: Barriers to Accessing New Anti-Diabetes Medications

EP. 4: Suspecting Hypercortisolism in Patients With Resistant Diabetes

EP. 5: Testing for Hypercortisolism

EP. 6: Patient Subgroups With a Higher Prevalence of Hypercortisolism

EP. 7: Evolving Perception of Autonomous Adrenal Hypercortisolism

EP. 8: Pathophysiology of Hypercortisolism

EP. 9: Need to Address Underlying Hypercortisolism

Now Viewing

EP. 10: Approaching Treatment in Hypercortisolism

EP. 11: Choosing Between Medical and Surgical Options for Hypercortisolism

EP. 12: Long-Term Outcomes for Patients Treated for Hypercortisolism